Vimarsana
Biggest News Aggregation in the World

Page 3 - Launch Readiness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Launch Readiness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Launch Readiness Today - Breaking & Trending Today

Sorry, Europe: AstraZeneca follows Pfizer/BioNTech in cutting back EU vaccine delivery plans - Vimarsana News

Sorry, Europe: AstraZeneca follows Pfizer/BioNTech in cutting back EU vaccine delivery plans

Jan 22, 2021 11:14am AstraZeneca has reportedly notified EU officials of a reduction in expected first-quarter coronavirus vaccine deliveries. (AstraZeneca) As AstraZeneca nears European authorization for its highly anticipated COVID-19 vaccine, the drugmaker has notified officials that initial shipments will come in lighter than originally expected. Two German-language publications, Bild and oe24, report that AZ notified EU officials this week that its first-quarter deliveries will come in lower than originally expected. An AstraZeneca spokesperson attributed the dip to "reduced yields at...

Eli Lilly's COVID-19 antibody shows it can prevent the disease. But will doctors use it? - Vimarsana News

Eli Lilly's COVID-19 antibody shows it can prevent the disease. But will doctors use it?

Jan 22, 2021 10:55am Eli Lilly said its antibody drug amlanivimab prevented symptomatic COVID-19 in nursing home residents and staffers. (GagliardiPhotography/Shutterstock) Eli Lilly’s bamlanivimab was the first antibody drug the FDA authorized to treat COVID-19. Now, the Indianapolis pharma has data showing the therapy prevents symptomatic infections. The catch? The data are limited to long-term care facilities, where vaccination is now underway—and despite their utility, antibody therapies are having a tough time catching on. Bamlanivimab cut the risk of developing symptomatic COVID-19 ...

Cognate beefs up cell, gene therapy manufacturing with new plants in U.S., EU - Vimarsana News

Cognate beefs up cell, gene therapy manufacturing with new plants in U.S., EU

Jan 22, 2021 3:45pm CDMO Cognate BioServices started work on a new commercial manufacturing plant that will nearly double capacity at its current headquarters in Memphis, Tennessee. (Cunaplus_M.Faba/iStock/Getty Images Plus) With the demand for cell and gene therapies mounting, CDMO Cognate BioServices is looking to swiftly expand its U.S. headquarters with two new facilities—and it's not stopping there. Its dedicated gene therapy unit, Cobra Biologics, is plotting its own scale-ups in Europe.  Stateside, Cognate is building out its global manufacturing facility and headquarters in Memph...

Remember normal? Pfizer and BioNTech join with health groups to remind us—and promote COVID-19 vaccine safety - Vimarsana News

Remember normal? Pfizer and BioNTech join with health groups to remind us—and promote COVID-19 vaccine safety

Jan 21, 2021 10:25am Pfizer and BioNTech join with health groups to promote “Science can make this possible. Only you can make it real,” COVID-19 awareness campaign.(Getty/Meyer & Meyer) Remember hugging, playing with grandchildren, kissing people goodbye and sharing exciting news with family in person? While COVID-19 has kiboshed those things, Pfizer and BioNTech want to remind people about them—and how they'll be possible again with vaccines.  The Comirnaty vaccine makers, together with a coalition of health organizations, recently debuted an awareness campaign aimed at shoring ...

France, unions push Sanofi for no layoffs during cost-cutting drive: report - Vimarsana News

France, unions push Sanofi for no layoffs during cost-cutting drive: report

Sanofi CEO Paul Hudson’s restructuring plan for the French pharma includes almost 1,700 job cuts in Europe, but local government officials and employees aren't fans of the idea. As the French government pushes for no forced departures, some union members have taken to the streets.